165 related articles for article (PubMed ID: 37001380)
1. CCL17 acts as an antitumor chemokine in micromilieu-driven immune skewing.
Li Y; Cao H; Jiang Z; Yan K; Shi J; Wang S; Wang F; Wang W; Li X; Sun N; Liu L; Chen L; Chen Y; Guo R; Song Y
Int Immunopharmacol; 2023 May; 118():110078. PubMed ID: 37001380
[TBL] [Abstract][Full Text] [Related]
2. Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity.
Kusumoto M; Xu B; Shi M; Matsuyama T; Aoyama K; Takeuchi T
J Interferon Cytokine Res; 2007 Nov; 27(11):901-10. PubMed ID: 18052724
[TBL] [Abstract][Full Text] [Related]
3. Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung.
Santulli-Marotto S; Boakye K; Lacy E; Wu SJ; Luongo J; Kavalkovich K; Coelho A; Hogaboam CM; Ryan M
PLoS One; 2013; 8(12):e81465. PubMed ID: 24339934
[TBL] [Abstract][Full Text] [Related]
4. T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.
Di Stasi A; De Angelis B; Rooney CM; Zhang L; Mahendravada A; Foster AE; Heslop HE; Brenner MK; Dotti G; Savoldo B
Blood; 2009 Jun; 113(25):6392-402. PubMed ID: 19377047
[TBL] [Abstract][Full Text] [Related]
5. CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.
Kumai T; Nagato T; Kobayashi H; Komabayashi Y; Ueda S; Kishibe K; Ohkuri T; Takahara M; Celis E; Harabuchi Y
Cancer Immunol Immunother; 2015 Jun; 64(6):697-705. PubMed ID: 25754123
[TBL] [Abstract][Full Text] [Related]
6. [Changes of TRGV genes and prognosis-related chemokine/receptor gene expressions in T cell lymphoma].
Luo Q; Jin Z; Chen S; Yang L; Li B; Li W; Li Y; Wu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Mar; 33(3):362-366. PubMed ID: 28274317
[TBL] [Abstract][Full Text] [Related]
7. Chemokine receptor 4 expression on blood T lymphocytes predicts severity of major depressive disorder.
Freff J; Beins EC; Bröker L; Schwarte K; Leite Dantas R; Maj C; Arolt V; Dannlowski U; Nöthen MM; Baune BT; Forstner AJ; Alferink J
J Affect Disord; 2022 Aug; 310():343-353. PubMed ID: 35526724
[TBL] [Abstract][Full Text] [Related]
8. Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice.
Jakubzick C; Wen H; Matsukawa A; Keller M; Kunkel SL; Hogaboam CM
Am J Pathol; 2004 Oct; 165(4):1211-21. PubMed ID: 15466387
[TBL] [Abstract][Full Text] [Related]
9. Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis.
Yogo Y; Fujishima S; Inoue T; Saito F; Shiomi T; Yamaguchi K; Ishizaka A
Respir Res; 2009 Aug; 10(1):80. PubMed ID: 19715610
[TBL] [Abstract][Full Text] [Related]
10. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.
Iellem A; Mariani M; Lang R; Recalde H; Panina-Bordignon P; Sinigaglia F; D'Ambrosio D
J Exp Med; 2001 Sep; 194(6):847-53. PubMed ID: 11560999
[TBL] [Abstract][Full Text] [Related]
11. CCL17 and CCL22 induce CCR4 receptor expression and promote cytokine-induced killer cells migration.
Dong Y; Gao S; Zhang X; Kou J; Liu J; Ye T; Shen H
Anticancer Drugs; 2022 Feb; 33(2):149-157. PubMed ID: 34657098
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.
Olkhanud PB; Baatar D; Bodogai M; Hakim F; Gress R; Anderson RL; Deng J; Xu M; Briest S; Biragyn A
Cancer Res; 2009 Jul; 69(14):5996-6004. PubMed ID: 19567680
[TBL] [Abstract][Full Text] [Related]
13. Evidence that phospholipase-C-dependent, calcium-independent mechanisms are required for directional migration of T-lymphocytes in response to the CCR4 ligands CCL17 and CCL22.
Cronshaw DG; Kouroumalis A; Parry R; Webb A; Brown Z; Ward SG
J Leukoc Biol; 2006 Jun; 79(6):1369-80. PubMed ID: 16614259
[TBL] [Abstract][Full Text] [Related]
14. Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.
Viney JM; Andrew DP; Phillips RM; Meiser A; Patel P; Lennartz-Walker M; Cousins DJ; Barton NP; Hall DA; Pease JE
J Immunol; 2014 Apr; 192(7):3419-27. PubMed ID: 24563252
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema.
Tapia B; Morel E; Martín-Díaz MA; Díaz R; Alves-Ferreira J; Rubio P; Padial A; Bellón T
Clin Exp Allergy; 2007 May; 37(5):704-13. PubMed ID: 17456218
[TBL] [Abstract][Full Text] [Related]
16. Reduced locomotor activity and exploratory behavior in CC chemokine receptor 4 deficient mice.
Ambrée O; Klassen I; Förster I; Arolt V; Scheu S; Alferink J
Behav Brain Res; 2016 Nov; 314():87-95. PubMed ID: 27469058
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of Th2 chemokine receptors on T cells from atopic and nonatopic asthmatics in response to Der p 1-pulsed dendritic cells.
Maneechotesuwan K; Wongkajornsilp A; Huabprasert S; Kasetsinsombat K; Suthumansami T
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S62-70. PubMed ID: 20364559
[TBL] [Abstract][Full Text] [Related]
18. CCL17 and CCL22 chemokines are upregulated in human obesity and play a role in vascular dysfunction.
Hueso L; Marques P; Morant B; Gonzalez-Navarro H; Ortega J; Real JT; Sanz MJ; Piqueras L
Front Endocrinol (Lausanne); 2023; 14():1154158. PubMed ID: 37124725
[TBL] [Abstract][Full Text] [Related]
19. Surrogate antibodies that specifically bind and neutralize CCL17 but not CCL22.
Santulli-Marotto S; Fisher J; Petley T; Boakye K; Panavas T; Luongo J; Kavalkovich K; Rycyzyn M; Wu B; Gutshall L; Coelho A; Hogaboam CM; Ryan M
Monoclon Antib Immunodiagn Immunother; 2013 Jun; 32(3):162-71. PubMed ID: 23750473
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4.
Imai T; Chantry D; Raport CJ; Wood CL; Nishimura M; Godiska R; Yoshie O; Gray PW
J Biol Chem; 1998 Jan; 273(3):1764-8. PubMed ID: 9430724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
